Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Argus Health
Citi
Queensland Health
UBS
Harvard Business School
Baxter
Cerilliant
Colorcon
Merck

Generated: October 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,388,029

« Back to Dashboard

Summary for Patent: 7,388,029

Title:Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
Abstract:A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth.
Inventor(s): DeLong; Mitchell Anthony (West Chester, OH), McIver; John McMillan (Cincinnati, OH), Youngquist; Robert Scott (Mason, OH)
Assignee: Duke University (Durham, NC)
Application Number:11/138,097
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;

Applicant Tradename Generic Name Dosage NDA Number Approval Date Type RLD Patent No. Product Substance Delist_Flag Patent Expiration Patented / Exclusive Use
bimatoprost
022369► SubscribeY► SubscribeTREATMENT OF HAIR LOSS AND HYPOTRICHOSIS OF THE EYELASHES BY INCREASING THEIR GROWTH INCLUDING LENGTH, THICKNESS AND DARKNESS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 7,388,029

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan2017101083► Subscribe
Japan2015134831► Subscribe
Japan2014043451► Subscribe
Japan2012046546► Subscribe
Japan2003528899► Subscribe
Spain2252215► Subscribe
European Patent Office1267807► Subscribe
Germany60115000► Subscribe
China101897700► Subscribe
China101229171► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Teva
Healthtrust
Medtronic
UBS
Fish and Richardson
Johnson and Johnson
Daiichi Sankyo
Colorcon
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot